{
  "ticker": "ANR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964665",
  "id": "02964665",
  "pages": 4,
  "price_sensitive": false,
  "date": "20250701",
  "time": "1710",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06lbsn5th85krs.pdf",
  "summary": "### **Substantial Holder Notice Summary (Form 604)**  \n\n- **Holder**: TIGA Trading Pty Ltd & associates (Thorney Investment Group)  \n- **Company**: Anatara Lifesciences Limited (ASX: ANR)  \n- **Key Changes**:  \n  - **Share Purchase (23-Dec-24)**: Acquired 600,000 ordinary shares via SPP ($30,000 total consideration).  \n  - **Market Sale (27-Jun-25)**: Sold 2,838,934 ordinary shares ($14,194.67 total consideration).  \n- **Current Holding**: 18,803,798 ordinary shares (8.81% voting power), down from 20,442,732 (9.83%).  \n\n**No other material information identified**.",
  "usage": {
    "prompt_tokens": 2427,
    "completion_tokens": 162,
    "total_tokens": 2589,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T07:12:29.398504"
}